Cargando…

Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study

Low ADAMTS13 activity is associated with an increased risk of cardiovascular disease, which is generally attributed to its proteolytic effects on Von Willebrand factor (VWF). Cardiovascular health is an important determinant of cognitive decline, but the association of either VWF or ADAMTS13 with ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolters, Frank J., Boender, Johan, de Vries, Paul S., Sonneveld, Michelle A., Koudstaal, Peter J., de Maat, Moniek P., Franco, Oscar H., Ikram, M. Kamran, Leebeek, Frank W., Ikram, M. Arfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882924/ https://www.ncbi.nlm.nih.gov/pubmed/29615758 http://dx.doi.org/10.1038/s41598-018-23865-7

Ejemplares similares

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Performance Related Factors Are the Main Determinants of the von Willebrand Factor Response to Exhaustive Physical Exercise
por: van Loon, Janine E., et al.
Publicado: (2014)

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study
por: de Vries, Paul S., et al.
Publicado: (2016)

Effect of Genetic Variation in STXBP5 and STX2 on von Willebrand Factor and Bleeding Phenotype in Type 1 von Willebrand Disease Patients
por: van Loon, Janine E., et al.
Publicado: (2012)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding
por: Atiq, Ferdows, et al.
Publicado: (2021)

The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022)

Life expectancy with and without dementia in persons with mild cognitive impairment in the community
por: Mooldijk, Sanne S., et al.
Publicado: (2021)

Proteolytic Processing of Von Willebrand Factor by Adamts13 and Leukocyte Proteases
por: Lancellotti, Stefano, et al.
Publicado: (2013)

ADAMTS‐13 and von Willebrand factor: a dynamic duo
por: South, K., et al.
Publicado: (2017)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021)

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018)

How I manage severe von Willebrand disease
por: Leebeek, Frank W. G., et al.
Publicado: (2019)

Biological variations of ADAMTS13 and von Willebrand factor in human adults
por: Kilercik, Meltem, et al.
Publicado: (2014)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2017)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
por: Reardon, Benjamin, et al.
Publicado: (2021)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
por: Colonne, Chanukya K., et al.
Publicado: (2022)

Circulating Myeloperoxidase (MPO)-DNA complexes as marker for Neutrophil Extracellular Traps (NETs) levels and the association with cardiovascular risk factors in the general population
por: Donkel, Samantha J., et al.
Publicado: (2021)

Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease
por: Sauna, Zuben E., et al.
Publicado: (2009)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2020)

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
por: Dolgushina, Nataliya, et al.
Publicado: (2022)

New Developments in Diagnosis and Management of Acquired Hemophilia and Acquired von Willebrand Syndrome
por: Leebeek, Frank W. G.
Publicado: (2021)

Interaction of von Willebrand factor with blood cells in flow models: a systematic review
por: Arisz, Ryanne A., et al.
Publicado: (2022)

Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI
por: Wolters, Frank J., et al.
Publicado: (2019)

Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA
por: de Jong, Annika, et al.
Publicado: (2020)

Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13
por: Djamiatun, Kis, et al.
Publicado: (2012)

Current and Emerging Options for the Management of Inherited von Willebrand Disease
por: Heijdra, Jessica M., et al.
Publicado: (2017)

Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study
por: Wolters, Frank J., et al.
Publicado: (2016)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
por: Swinkels, Maurice, et al.
Publicado: (2021)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
por: Soares, R.P.S., et al.
Publicado: (2013)

A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor
por: South, Kieron, et al.
Publicado: (2017)

Histone-induced thrombotic thrombocytopenic purpura in adamts13(−/−) zebrafish depends on von Willebrand factor
por: Zheng, Liang, et al.
Publicado: (2020)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
por: Yang, Junxian, et al.
Publicado: (2020)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients
por: Singh, Kanwal, et al.
Publicado: (2021)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
por: MacArthur, Taleen A, et al.
Publicado: (2021)

Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
por: Marco, A, et al.
Publicado: (2021)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
por: Wysokinski, Waldemar E., et al.
Publicado: (2020)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
por: Ahmed, Abdulla, et al.
Publicado: (2021)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
por: Bashir, Dalia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7d7ica9fembt32mm9psj70d70e